MedTrace Logo

Oral Contraceptive Consumption Timing and Cognition and Metabolism

NCT06560944 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2024-08-21

No results posted yet for this study

Summary

The aim of this randomised-controlled trial is to examine whether the timing of oral contraceptive administration affects cognitive function, substrate metabolism and exercise performance.

Participants will attend the laboratory for a familiarisation session, followed by two main trials in which cognition and exercise metabolism and performance are measured. In one trial they will be given their oral contraceptive 60 minutes before testing begins, in the other they will be given a placebo. Following testing (\~60 minutes), participants will consume the alternative pill.

Conditions

  • Cognitive Change

Interventions

DRUG

Combined oral contraceptive pill

Ingesting their existing combined oral contraceptive pill at a specific time of day in relation to assessment of outcome measures

Sponsors & Collaborators

  • University of Lincoln

    lead OTHER

Principal Investigators

  • Dan Martin, PhD · University of Lincoln

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-17
Primary Completion
2024-01-20
Completion
2024-01-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06560944 on ClinicalTrials.gov